Downregulation of eEF1A/EFT3-4 Enhances Dopaminergic Neurodegeneration After 6-OHDA Exposure in C. elegans Model
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the aggregation of α-synuclein protein and selective death of dopaminergic (DA) neurons in the substantia nigra of the midbrain. Although the molecular pathogenesis of PD is not completely understood, a recent study has report...
Main Authors: | Pawanrat Chalorak, Permphan Dharmasaroja, Krai Meemon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2020.00303/full |
Similar Items
-
Mechanistic studies and drug discovery for eEF-2 kinase
by: Devkota, Ashwini Kumar
Published: (2013) -
Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota
by: Nawaphat Malaiwong, et al.
Published: (2019-01-01) -
Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease
by: Justyna B. Mocko, et al.
Published: (2010-10-01) -
Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma
by: Zhao YY, et al.
Published: (2018-08-01) -
Role of eEF1A in the Nuclear Export of the VHL Tumour Suppressor Protein
by: Francisco, Camille
Published: (2012)